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Blood and dialyzer membrane interaction can cause signiﬁcant thrombocytopenia through the activation of complement system.
The extent of this interaction determines the biocompatibility of the membrane. Although the newer synthetic membranes
have been shown to have better biocompatibility proﬁle than the cellulose-based membranes, little is known about the
diﬀerence in biocompatibility between synthetic membrane and modiﬁed cellulose membrane. Herein, we report a case of a
patient on hemodialysis who developed dialyzer-membrane-related thrombocytopenia with use of synthetic membrane (F200NR
polysulfone). The diagnosis of dialyzer membrane-associated thrombocytopenia was suspected by the trend of platelet count
before and after dialysis, and the absence of other possible causes of thrombocytopenia. We observed signiﬁcant improvement in
platelet count when the membrane was changed to modiﬁed cellulose membrane (cellulose triacetate). In patients at high risk for
thrombocytopenia, the modiﬁed cellulose membrane could be a better alternative to the standard synthetic membranes during
hemodialysis.
1.Introduction
Thrombocytopenia is common in patients receiving he-
modialysis, and it is usually secondary to use of heparin,
uremia, sepsis, blood loss, and bone marrow suppression
[1].However, studieshaveshown thatthedialysis membrane
itselfcancausesigniﬁcant thrombocytopeniathroughtheac-
tivation of the complement system [2]. The degree to which
the dialyzer membrane activates the complement system
determines its biocompatibility. Hemodialysis initially relied
predominantly on the use of cellulose-based membranes
with poor biocompatibility proﬁle and associated thrombo-
cytopenia and leucopenia [3]. Modiﬁcation of the cellulose
membranes has greatly reduced these complications [4].
In recent time, membranes manufactured from synthetic
polymers are commonly used because of their superior
biocompatibility as compared to cellulose-based mem-
branes. However, whether the biocompatibility of synthetic
membrane is superior to that of synthetically modiﬁed
cellulose membrane remains unclear. Herein, we report
a case of a 54-year-old female that developed dialyzer
membrane-associated thrombocytopenia while on hemo-
dialysis with synthetic membrane. The platelet count sig-
niﬁcantly increased when the membrane was changed to
modiﬁed cellulose.
2.Case Report
A 54-year-old female with history of longstanding hyper-
tension, diabetes, and hyperlipidemia, was admitted to the
hospital for persistent nausea and vomiting. She reported
taking nifedipine, lisinopril, clonidine, insulin, lipitor, and
aspirin at home. Initial blood testing showed white blood
count of 4.4×103 (normal: 3.8–10.8×103/UL), hemoglobin
of 10.2g/dL (normal: 13.2–17.1g/dL), platelet of 88 ×
103/UL (normal: 140–400×103/UL), blood urea nitrogen of2 Case Reports in Medicine
42mg/dL(normal:7–25mg/dL),andcreatinineof5.8mg/dL
(normal: 0.7–1.3mg/dL). Other laboratory tests were within
normal limits.
Dialysis was initiated for end-stage renal disease accord-
ing tothefollowing prescription: dialyzer, Fresenius Optiﬂux
F200NR (polysulfones synthetic dialyzer membrane, 2.0m2
surface area, and electron-beam sterilized); treatment time:
3 hours; no heparin was given because of baseline mild
thrombocytopenia. The treatment was well tolerated. Post-
dialysis platelet count dropped to 16,000/UL after the ﬁrst
dialysis session. The patient reported no episodesof bleeding
or bruising. Repeat platelet count was the same. Peripheral
smear showed few platelets and giant cells with no schisto-
cytes. Blood testing for heparin-induced thrombocytopenia
antibodies and cultures was negative. Serial platelet counts
were done for close monitoring and to determine the need
for transfusion. Gradual drop, then rise in platelet count to
baseline was noted overa 48-hr period. Following the second
dialysis session, similar pattern of fall and rise in platelet
count was noticed as shown in Figure 1. However both the
hemoglobin and white blood cell countremained stable. The
predialysis rise and postdialysis fall in platelet count raised
the suspicion for dialysis-related thrombocytopenia. At the
third dialysis session, dialyzer membrane was changed to
Baxter cellulose triacetate exceltra 210 (modiﬁed cellulose
dialyzer membrane, 2.1m2 surface area, gamma sterilized)
and the platelet count remained stable after dialysis.
3.Discussion
The interaction between blood constituents and dialyzer
membrane is increasingly being recognized as a major cause
of thrombocytopenia in dialysis patients [2]. The extent of
theseinteractionsisrelatedtothecompositionand geometry
of the membrane. Although the cellulose-based membranes
are less expensive, synthetic membranes are often used
because of their superior biocompatibility [5].
Cellulose membranes are composed of polysaccharide
units with hydroxyl groups which are responsible for the bio-
chemical interactions and associated complications through
the activation of the complement system. However, they are
less likely to provoke platelet activation and adhesion [6].
Modiﬁcations of these membranes by replacing the hydroxyl
groups with acetyl groups have been shown to improve the
biocompatibility proﬁle [7]. Synthetic membranes are made
up of hydrophobic materials with low tendency to activate
the complement system [6] .H o w e v e r ,t h e ya r em o r el i k e l y
to trigger platelet adhesion and thrombus formation which
may account for the observed decrease in platelet count
each time F200NR polysulfone synthetic dialyzer was used
in our patient. The improvement in platelet count following
the change of dialyzer membrane to cellulose triacetate
membrane may also be related to the reported improved
biocompatibility proﬁle of modiﬁed cellulose membranes
[7] .T h eb a s e l i n et h r o m b o c y t o p e n i ap r i o rt ot h ei n i t i a t i o no f
hemodialysis in our patient was most likely due to uremia
itself, given the negative workup for common causes of
thrombocytopenia.
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Figure 1: The trend ofplatelet counts before andafter hemodialysis
with polysulfone (PS) and cellulose triacetate (CTA) dialyzer
membrane.
Among 96 patients with thrombocytopenia and acute
kidney injury requiring continuous venovenous hemoﬁltra-
tion, signiﬁcant drop in platelet count was observed in the
polysulfone without anticoagulation group but not in the
cellulose triacetate without anticoagulation group [8]. This
ﬁnding is consistent with the observation in our patient.
In another study comparing the inﬂuence of cellulose
triacetate (CTA) and polysulfone (PS) membrane on platelet
activation, the level of bound GPIIb/IIIa was signiﬁcantly
higher in the polysulfone group [9]. The present case report
is consistent with the ﬁndings of these studies and further
highlights the usefulness of the cheap cellulose-based mem-
brane in patients at high risk for thrombocytopenia. The
main clue to the diagnosis of dialyzer-membrane-induced
thrombocytopenia in this patient was the trend of platelet
counts and absence of other common causes of thrombocy-
topenia. We are not aware of any prior similar case report.
4.Conclusion
In patients at high risk for thrombocytopenia during
hemodialysis, the modiﬁed cellulose membranes could be
a better alternative to the standard synthetic membranes in
preventing dialyzer membrane-associated thrombocytope-
nia. Peridialysis pattern of platelet counts may provide a clue
to the diagnosis of dialysis-associated thrombocytopenia.
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